A short D-enantiomeric antimicrobial peptide with potent immunomodulatory and antibiofilm activity against multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii

Abstract Antimicrobial peptides (AMPs) represent a promising therapeutic alternative for the treatment of antibiotic-resistant bacterial infections. The present study investigates the antimicrobial activity of new, rationally-designed derivatives of a short α-helical peptide, RR. From the peptides d...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mohamed F. Mohamed, Anna Brezden, Haroon Mohammad, Jean Chmielewski, Mohamed N. Seleem
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/5369fd7d7b3c42f8b424b36262d3446f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5369fd7d7b3c42f8b424b36262d3446f
record_format dspace
spelling oai:doaj.org-article:5369fd7d7b3c42f8b424b36262d3446f2021-12-02T15:05:36ZA short D-enantiomeric antimicrobial peptide with potent immunomodulatory and antibiofilm activity against multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii10.1038/s41598-017-07440-02045-2322https://doaj.org/article/5369fd7d7b3c42f8b424b36262d3446f2017-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-07440-0https://doaj.org/toc/2045-2322Abstract Antimicrobial peptides (AMPs) represent a promising therapeutic alternative for the treatment of antibiotic-resistant bacterial infections. The present study investigates the antimicrobial activity of new, rationally-designed derivatives of a short α-helical peptide, RR. From the peptides designed, RR4 and its D-enantiomer, D-RR4, emerged as the most potent analogues with a more than 32-fold improvement in antimicrobial activity observed against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii. Remarkably, D-RR4 demonstrated potent activity against colistin-resistant strains of P. aeruginosa (isolated from cystic fibrosis patients) indicating a potential therapeutic advantage of this peptide over several AMPs. In contrast to many natural AMPs, D-RR4 retained its activity under challenging physiological conditions (high salts, serum, and acidic pH). Furthermore, D-RR4 was more capable of disrupting P. aeruginosa and A. baumannii biofilms when compared to conventional antibiotics. Of note, D-RR4 was able to bind to lipopolysaccharide to reduce the endotoxin-induced proinflammatory cytokine response in macrophages. Finally, D-RR4 protected Caenorhabditis elegans from lethal infections of P. aeruginosa and A. baumannii and enhanced the activity of colistin in vivo against colistin-resistant P. aeruginosa.Mohamed F. MohamedAnna BrezdenHaroon MohammadJean ChmielewskiMohamed N. SeleemNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-13 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Mohamed F. Mohamed
Anna Brezden
Haroon Mohammad
Jean Chmielewski
Mohamed N. Seleem
A short D-enantiomeric antimicrobial peptide with potent immunomodulatory and antibiofilm activity against multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii
description Abstract Antimicrobial peptides (AMPs) represent a promising therapeutic alternative for the treatment of antibiotic-resistant bacterial infections. The present study investigates the antimicrobial activity of new, rationally-designed derivatives of a short α-helical peptide, RR. From the peptides designed, RR4 and its D-enantiomer, D-RR4, emerged as the most potent analogues with a more than 32-fold improvement in antimicrobial activity observed against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii. Remarkably, D-RR4 demonstrated potent activity against colistin-resistant strains of P. aeruginosa (isolated from cystic fibrosis patients) indicating a potential therapeutic advantage of this peptide over several AMPs. In contrast to many natural AMPs, D-RR4 retained its activity under challenging physiological conditions (high salts, serum, and acidic pH). Furthermore, D-RR4 was more capable of disrupting P. aeruginosa and A. baumannii biofilms when compared to conventional antibiotics. Of note, D-RR4 was able to bind to lipopolysaccharide to reduce the endotoxin-induced proinflammatory cytokine response in macrophages. Finally, D-RR4 protected Caenorhabditis elegans from lethal infections of P. aeruginosa and A. baumannii and enhanced the activity of colistin in vivo against colistin-resistant P. aeruginosa.
format article
author Mohamed F. Mohamed
Anna Brezden
Haroon Mohammad
Jean Chmielewski
Mohamed N. Seleem
author_facet Mohamed F. Mohamed
Anna Brezden
Haroon Mohammad
Jean Chmielewski
Mohamed N. Seleem
author_sort Mohamed F. Mohamed
title A short D-enantiomeric antimicrobial peptide with potent immunomodulatory and antibiofilm activity against multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii
title_short A short D-enantiomeric antimicrobial peptide with potent immunomodulatory and antibiofilm activity against multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii
title_full A short D-enantiomeric antimicrobial peptide with potent immunomodulatory and antibiofilm activity against multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii
title_fullStr A short D-enantiomeric antimicrobial peptide with potent immunomodulatory and antibiofilm activity against multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii
title_full_unstemmed A short D-enantiomeric antimicrobial peptide with potent immunomodulatory and antibiofilm activity against multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii
title_sort short d-enantiomeric antimicrobial peptide with potent immunomodulatory and antibiofilm activity against multidrug-resistant pseudomonas aeruginosa and acinetobacter baumannii
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/5369fd7d7b3c42f8b424b36262d3446f
work_keys_str_mv AT mohamedfmohamed ashortdenantiomericantimicrobialpeptidewithpotentimmunomodulatoryandantibiofilmactivityagainstmultidrugresistantpseudomonasaeruginosaandacinetobacterbaumannii
AT annabrezden ashortdenantiomericantimicrobialpeptidewithpotentimmunomodulatoryandantibiofilmactivityagainstmultidrugresistantpseudomonasaeruginosaandacinetobacterbaumannii
AT haroonmohammad ashortdenantiomericantimicrobialpeptidewithpotentimmunomodulatoryandantibiofilmactivityagainstmultidrugresistantpseudomonasaeruginosaandacinetobacterbaumannii
AT jeanchmielewski ashortdenantiomericantimicrobialpeptidewithpotentimmunomodulatoryandantibiofilmactivityagainstmultidrugresistantpseudomonasaeruginosaandacinetobacterbaumannii
AT mohamednseleem ashortdenantiomericantimicrobialpeptidewithpotentimmunomodulatoryandantibiofilmactivityagainstmultidrugresistantpseudomonasaeruginosaandacinetobacterbaumannii
AT mohamedfmohamed shortdenantiomericantimicrobialpeptidewithpotentimmunomodulatoryandantibiofilmactivityagainstmultidrugresistantpseudomonasaeruginosaandacinetobacterbaumannii
AT annabrezden shortdenantiomericantimicrobialpeptidewithpotentimmunomodulatoryandantibiofilmactivityagainstmultidrugresistantpseudomonasaeruginosaandacinetobacterbaumannii
AT haroonmohammad shortdenantiomericantimicrobialpeptidewithpotentimmunomodulatoryandantibiofilmactivityagainstmultidrugresistantpseudomonasaeruginosaandacinetobacterbaumannii
AT jeanchmielewski shortdenantiomericantimicrobialpeptidewithpotentimmunomodulatoryandantibiofilmactivityagainstmultidrugresistantpseudomonasaeruginosaandacinetobacterbaumannii
AT mohamednseleem shortdenantiomericantimicrobialpeptidewithpotentimmunomodulatoryandantibiofilmactivityagainstmultidrugresistantpseudomonasaeruginosaandacinetobacterbaumannii
_version_ 1718388765001515008